本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Agios Pharmaceuticals, Inc.

29.10
-0.5200-1.76%
盘后29.100.00000.00%16:32 EDT
成交量:47.34万
成交额:1,380.31万
市值:16.85亿
市盈率:2.50
高:29.68
开:29.68
低:28.94
收:29.62
数据加载中...
2025/04/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/13

重要事件披露

Form 8-K - Current report
2025/02/13

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

重要事件披露

Form 8-K - Current report
2025/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report